Enhanced and sustained topical ocular delivery of cyclosporine a in thermosensitive hyaluronic acid-based in situ forming microgels

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3587-3601

  Wu, Yijun ^a   Yao, Jing ^a   Zhou, Jianping ^a   Dahmani, Fatima Zohra ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cyclosporine a; Hyaluronic acid; Ophthalmic drug delivery; Thermosensitive microgels

Indexed keywords

AMIDE; CASTOR OIL; COPOLYMER; CYCLOSPORIN A; EYE DROPS; HYALURONIC ACID; HYALURONIC ACID POLY(N ISOPROPYLACRYLAMIDE) COPOLYMER; POLY(N ISOPROPYLACRYLAMIDE); UNCLASSIFIED DRUG;

AMINATION; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMICAL BOND; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORNEA; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; GEL; HEAT SENSITIVITY; MICROGEL; NONHUMAN; PARTICLE SIZE; RABBIT; SYNTHESIS; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

CYCLOSPORINE A; HYALURONIC ACID; OPHTHALMIC DRUG DELIVERY; THERMOSENSITIVE MICROGELS;

ADMINISTRATION, OPHTHALMIC; ANIMALS; CAPSULES; CYCLOSPORINE; DELAYED-ACTION PREPARATIONS; ENDOPHTHALMITIS; GELS; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENTS; RABBITS; TEMPERATURE;

EID: 84884579982     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S47665     Document Type: Article

References (43)

1. Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm. 1997;153(1): 41-50.
2. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57(11):1595-1639.
3. Nanjawade BK, Manvi FV, Manjappa AS. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release. 2007;122(2): 119-134.
4. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58(11):1131-1135.
5. Keister JC, Cooper ER, Missel PJ, Lang JC, Hager DF. Limits on optimizing ocular drug delivery. J Pharm Sci. 1991;80(1):50-53.
6. Asasutjarit R, Thanasanchokpibull S, Fuongfuchat A, Veeranondha S. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. Int J Pharm. 2011;411(1-2):128-135.
7. Mahmoud AA, El-Feky GS, Kamel R, Awad GE. Chitosan/ sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm. 2011;413(1-2):229-236.
8. Wu C, Qi H, Chen W, Chen W, Huang C, et al. Preparation and evalua-tion of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi. 2007;127(1):183-191.
9. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23(12):2709-2728.
10. Yenice I, Mocan MC, Palaska E, et al. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentra-tions of cyclosporine A into the cornea. Exp Eye Res. 2008;87(3): 162-167.
11. Moya-Ortega MD, Alves TF, Alvarez-Lorenzo C, et al. Dexamethasone eye drops containing γ-cyclodextrin-based nanogels. Int J Pharm. 2013;441(1-2):507-515.
12. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nano-particles as drug delivery systems. Adv Drug Deliv Rev. 2008;60(15): 1650-1662.
13. Oh JK, Lee DI, Park JM. Biopolymer-based microgels/nanogels for drug delivery applications. Prog Polym Sci. 2009;34(12):1261-1282.
14. Oh EJ, Park K, Kim KS, et al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release. 2010;141(1):2-12.
15. Fonn D. Targeting contact lens induced dryness and discomfort: what properties will make lenses more comfortable. Optom Vis Sci. 2007;84(4):279-285.
16. Stuart JC, Linn JG. Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders. Ann Ophthalmol. 1985;17(3):190-192.
17. Kettel MJ, Dierkes F, Schaefer K, Moeller M, Pich A. Aqueous nanogels modified with cyclodextrin. Polymer. 2011;52(9):1917-1924.
18. Yang HW, Chen JK, Cheng CC, Kuo SW. Association of poly(N-isopropylacrylamide) containing nucleobase multiple hydrogen bonding of adenine for DNA recognition. Appl Surf Sci. 2013;271:60-69.
19. Liu W, Huang Y, Liu H, Hu Y. Composite structure of temperature sen-sitive chitosan microgel and anomalous behavior in alcohol solutions. J Colloid Interface Sci. 2007;313(1):117-121.
20. Tan H, Ramirez CM, Miljkovic N, Li H, Rubin JP, Marra KG. Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials. 2009;30(36):6844-6853.
21. Bloch P, Tamm C, Bollinger P, Petcher TJ, Weber HP. Pseurotin, a new metabolite of Pseudeurotium ovalis Stolk having an unusual hetero-spirocyclic system. Helv Chim Acta. 1976;59(1):133-137.
22. Kahan BD. Cyclosporin A: a new advance in transplantation. Tex Heart Inst J. 1982;9(3):253-266.
23. Hingorani M, Calder VL, Buckley RJ, Lightman S. The immunomodula-tory effect of topical cyclosporin A in atopic keratoconjunctivitis. Invest Ophthalmol Vis Sci. 1999;40(2):392-399.
24. Tang-Liu DD, Acheampong A. Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye. Clin Pharmacokinet. 2005;44(3):247-261.
25. Francis MF, Piredda M, Winnik FM. Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxypropy-lcellulose copolymers. J Control Release. 2003;93(1):59-68.
26. Gökçe EH, Sandri G, Eǧrilmez S, Bonferoni MC, Güneri T, Caramella C. Cyclosporine a-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes. Curr Eye Res. 2009;34(11):996-1003.
27. Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R. Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm. 2003;56(3):307-318.
28. Cao Y, Zhang C, Shen W, Cheng Z, Yu LL, Ping Q. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release. 2007;120(3): 186-194.
29. Hsiue GH, Hsu SH, Yang CC, Lee SH, Yang IK. Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. Biomaterials. 2002;23(2):457-462.
30. Gao C, Möhwald H, Shen J. Thermosensitive poly(allylamine)-g-poly(N-isopropylacrylamide): synthesis, phase separation and particle formation. Polymer. 2005;46(12):4088-4097.
31. Chai S, Zhang J, Yang T, Yuan J, Cheng S. Thermoresponsive microgel decorated with silica nanoparticles in shell: Biomimetic synthesis and drug release application. Colloids Surf A Physicochem Eng Asp. 2010; 356(1):32-39.
32. Bozdaǧ S, Gümüş K, Gümüş O, Unlü N. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis. Eur J Pharm Biopharm. 2008;70(1): 260-269.
33. Zhou L, Tan D, Theng J, Lim L, Liu YP, Lam KW. Optimized analytical method for cyclosporin A by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl. 2001;754(1):201-207.
34. Yeo Y, Highley CB, Bellas E, et al. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. Biomaterials. 2006;27(27):4698-4705.
35. Chen JP, Cheng TH. Preparation and evaluation of thermo-reversible copolymer hydrogels containing chitosan and hyaluronic acid as inject-able cell carriers. Polymer. 2009;50(1):107-116.
36. Lin CL, Chiu WY, Lee CF. Thermal/pH-sensitive core-shell copolymer latex and its potential for targeting drug carrier application. Polymer. 2005;46(23):10092-10101.
37. Yi F, Zheng S. Effect of hydrophobic polystyrene microphases on temperature-responsive behavior of poly(N-isopropylacrylamide) hydrogels. Polymer. 2009;50(2):670-678.
38. Zhao H, Chen H, Li Z, Su W, Zhang Q. The synthesis of temperature-sensitive PMMA-coating PNIPAM particles via a rapid microwave-assisted polymerization. Eur Polym J. 2006;42(9):2192-2198.
39. Hao Y, Peng J, Li J, Zhai M, Wei G. An ionic liquid as reaction media for radiation-induced grafting of thermosensitive poly (N-isopropylacryl-amide) onto microcrystalline cellulose. Carbohydr Polym. 2009;77(4): 779-784.
40. Khan A. Preparation and characterization of N-isopropylacrylamide/ acrylic acid copolymer core-shell microgel particles. J Colloid Interface Sci. 2007;313(2):697-704.
41. Wang M, Fang Y, Hu D. Preparation and properties of chitosan-poly(N-isopropylacrylamide) full-IPN hydrogels. React Funct Polym. 2001;48:215-221.
42. Kaswan RL. Intraocular penetration of topically applied cyclosporine. Transplant Proc. 1988;20(Suppl 2):650-655.
43. Kobayashi J, Okano T. Thermoresponsive thin hydrogel-grafted sur-faces for biomedical applications. React Funct Polym. 2013;73(7): 939-944.